MobiHealthNews

AccurKardia receives patent for AI-ECG cardiac amyloidosis detection

The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...

AI-ECG: A New Market For A Century-Old Test

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...
News Medical

Improved diagnosis of occlusion myocardial infarction using novel machine learning tools

In a recently published study in the journal Nature Medicine, researchers developed and tested an intelligent model for diagnosing patients with occlusion myocardial infarction (OMI). This model was ...
BioWorld

Heartsciences’ Myovista AI ECG cost-effectively stratifies cardiac risk, study shows

Heart Test Laboratories Inc., doing business as Heartsciences, said an independent study shows its Myovista electrocardiogram (ECG) machine learning model could be a cost-effective way to predict and ...
The Caledonian-Record

AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis

AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced that ...